Some natural compounds and their analogues having potent anti- SARS-CoV-2 and anti-proteases activities as lead molecules in drug discovery for COVID-19
Currently an emerging human pathogenic coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), caused coronavirus disease 2019 (COVID-19) that has posed a serious threat to public health worldwide. As it is a novel severe pneumonia-type viral disease, no effective therapeutic agen...
Saved in:
Main Authors: | Biswanath Dinda (Author), Manikarna Dinda (Author), Subhajit Dinda (Author), Mithun Chakraborty (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-O-gallate (EGCG) in SARS-CoV-2 infection: Major interactions with host/virus proteases
by: Biswanath Dinda, et al.
Published: (2023) -
Anti-SARS-CoV-2, antioxidant and immunomodulatory potential of dietary flavonol quercetin: Focus on molecular targets and clinical efficacy
by: Biswanath Dinda, et al.
Published: (2024) -
Therapeutic potential of natural alkaloid emetine against emerging COVID-19 and future viral pandemics
by: Biswanath Dinda, et al.
Published: (2024) -
Discovery of talmapimod analogues as polypharmacological anti-inflammatory agents
by: Wandong Liu, et al.
Published: (2020) -
Discovery and characterization of novel potent non-covalent small molecule inhibitors targeting papain-like protease from SARS-CoV-2
by: Miao Zheng, et al.
Published: (2024)